Arbutus Health Group is an Irish company seeking to provide high-quality, medicinal cannabis products to Irish people through licensed import from Canada and eventually through legal production in Ireland.
Our immediate goal is to afford Irish patients the opportunity to access reliable, affordable and high-quality medicines. We diligently screen and carefully select our manufacturers to ensure that the highest production standards are upheld. These standardized products are available for immediate export and meet the recommendations set out by the Health Products Regulatory Authority (HPRA).
These medicines are produced in full compliance with both European and Canadian quality assurance standards and are intended for the following medical conditions set out by the HPRA:
- Spasticity associated with multiple sclerosis
- Intractable nausea and vomiting associated with chemotherapy
- Severe, refractory (treatment-resistant) epilepsy
Our wider range of products are currently administered to Canadian patients living with serious health challenges such as cancer, HIV/AIDS, arthritis and fibromyalgia. Our medicines are also prescribed to patients needing chronic pain management and palliative care.